Effect of the α2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey
- 1 October 1999
- journal article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 23 (7) , 1237-1246
- https://doi.org/10.1016/s0278-5846(99)00067-6
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Presymptomatic revelation of experimental ParkinsonismNeuroReport, 1997
- Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: A microdialysis studyLife Sciences, 1992
- Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's diseaseAnnals of Neurology, 1990
- Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in ratNeuropharmacology, 1987
- Prevention of reserpine rigidity by alpha-2 adrenergic antagonistsPharmacology Biochemistry and Behavior, 1982
- Origin and organization of brainstem catecholamine innervation in the ratJournal of Comparative Neurology, 1979
- Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndromeJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1977
- Reserpine rigidity and adrenergic neuronesNeuropharmacology, 1973
- ParkinsonismNeurology, 1967
- THE BRAIN-STEM LESIONS IN PARKINSONISMJournal of Neurology, Neurosurgery & Psychiatry, 1953